Anthera Pharma (ANTH) Prices 60.6M Offering at 66c/Share

Article Related Press Releases (2) Stock Quotes (1) Comments (0)

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced the pricing of an underwritten public offering of 60,606,061 shares of its common stock, offered at a price of $0.66 per share. The Company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million. The offering is expected to close on or about January 30, 2013, subject to customary closing conditions. In addition, Anthera has granted the underwriters a 30-day option to purchase up to an additional 9,090,909 shares of common stock. The Company intends to use the net proceeds from the offering for general corporate purposes.

Jefferies & Company, Inc. is acting as sole book-running manager in the offering and Leerink Swann LLC is acting as co-manager. Trout Capital LLC has acted as an advisor to the Company.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
• Ligand Pharmaceuticals (LGND) Agreement with Merck KGaA Unit Terminated
• General Electric (GE) Capital Will Pay $6.5B in Dividends to GE

Create E-mail Alert Related Categories

Corporate News, Equity Offerings

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?